Ujin Pharma Ltd.

Revenue Concentration Risk

A significant share of revenue comes from sales in India, particularly from Maharashtra and Gujarat, representing 78.19% to 85.45% of total revenue.

Operational · medium

Supplier Dependence Risk

The company imports significant chemical products, with international purchases representing 26.56% to 33.61% of total purchases.

Operational · medium

Customer Dependence Risk

The company does not have long-term agreements with customers, and its top 10 customers contributed 27.04% to 32.64% of revenue.